vimarsana.com
Home
Live Updates
Altimmune : Evercore ISI NASH Renaissance 2023 Presentation : comparemela.com
Altimmune : Evercore ISI NASH Renaissance 2023 Presentation
NASH Renaissance 2023
Pemvidutide-Potent GLP-1/Glucagon Dual Receptor Agonist for the Treatment of NASH and Obesity
Evercore ISI Research... | March 30, 2023
Related Keywords
Scresecnrinege Rnsaicnrgdeoemniiznagtion ,
Nasdaq ,
Research Event ,
Altimmune Inc ,
Exchange Commission ,
Glucagon Dual Receptor Agonist ,
Private Securities Litigation Reform Act ,
Altimmune ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Cash ,
Renaissance ,
Ual ,
Eceptor ,
Agonist ,
Or ,
The ,
Treatment ,
F ,
End ,
Evercore ,
Si Alt Us02155h2004 ,
comparemela.com © 2020. All Rights Reserved.